Cargando…
Addendum: A case series of advanced renal cell carcinoma patients treated with neoadjuvant cabozantinib prior to cytoreductive nephrectomy within the phase 2 CABOPRE trial
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359456/ https://www.ncbi.nlm.nih.gov/pubmed/36455393 http://dx.doi.org/10.18632/oncotarget.28263 |
| _version_ | 1784764142099365888 |
|---|---|
| author | de Velasco, Guillermo Carril-Ajuria, Lucia Guerrero-Ramos, Felix Alonso-Gordoa, Teresa Rodríguez-Moreno, Juan F. Carretero, Alberto Martin-Soberon, Maricruz de la Rosa-Kehrmann, Federico Castellano, Daniel |
| author_facet | de Velasco, Guillermo Carril-Ajuria, Lucia Guerrero-Ramos, Felix Alonso-Gordoa, Teresa Rodríguez-Moreno, Juan F. Carretero, Alberto Martin-Soberon, Maricruz de la Rosa-Kehrmann, Federico Castellano, Daniel |
| author_sort | de Velasco, Guillermo |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9359456 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Impact Journals LLC |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-93594562022-08-09 Addendum: A case series of advanced renal cell carcinoma patients treated with neoadjuvant cabozantinib prior to cytoreductive nephrectomy within the phase 2 CABOPRE trial de Velasco, Guillermo Carril-Ajuria, Lucia Guerrero-Ramos, Felix Alonso-Gordoa, Teresa Rodríguez-Moreno, Juan F. Carretero, Alberto Martin-Soberon, Maricruz de la Rosa-Kehrmann, Federico Castellano, Daniel Oncotarget Addendum Impact Journals LLC 2022-08-04 /pmc/articles/PMC9359456/ /pubmed/36455393 http://dx.doi.org/10.18632/oncotarget.28263 Text en Copyright: © 2022 de Velasco et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/3.0/) (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
| spellingShingle | Addendum de Velasco, Guillermo Carril-Ajuria, Lucia Guerrero-Ramos, Felix Alonso-Gordoa, Teresa Rodríguez-Moreno, Juan F. Carretero, Alberto Martin-Soberon, Maricruz de la Rosa-Kehrmann, Federico Castellano, Daniel Addendum: A case series of advanced renal cell carcinoma patients treated with neoadjuvant cabozantinib prior to cytoreductive nephrectomy within the phase 2 CABOPRE trial |
| title | Addendum: A case series of advanced renal cell carcinoma patients treated with neoadjuvant cabozantinib prior to cytoreductive nephrectomy within the phase 2 CABOPRE trial |
| title_full | Addendum: A case series of advanced renal cell carcinoma patients treated with neoadjuvant cabozantinib prior to cytoreductive nephrectomy within the phase 2 CABOPRE trial |
| title_fullStr | Addendum: A case series of advanced renal cell carcinoma patients treated with neoadjuvant cabozantinib prior to cytoreductive nephrectomy within the phase 2 CABOPRE trial |
| title_full_unstemmed | Addendum: A case series of advanced renal cell carcinoma patients treated with neoadjuvant cabozantinib prior to cytoreductive nephrectomy within the phase 2 CABOPRE trial |
| title_short | Addendum: A case series of advanced renal cell carcinoma patients treated with neoadjuvant cabozantinib prior to cytoreductive nephrectomy within the phase 2 CABOPRE trial |
| title_sort | addendum: a case series of advanced renal cell carcinoma patients treated with neoadjuvant cabozantinib prior to cytoreductive nephrectomy within the phase 2 cabopre trial |
| topic | Addendum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359456/ https://www.ncbi.nlm.nih.gov/pubmed/36455393 http://dx.doi.org/10.18632/oncotarget.28263 |
| work_keys_str_mv | AT develascoguillermo addendumacaseseriesofadvancedrenalcellcarcinomapatientstreatedwithneoadjuvantcabozantinibpriortocytoreductivenephrectomywithinthephase2cabopretrial AT carrilajurialucia addendumacaseseriesofadvancedrenalcellcarcinomapatientstreatedwithneoadjuvantcabozantinibpriortocytoreductivenephrectomywithinthephase2cabopretrial AT guerreroramosfelix addendumacaseseriesofadvancedrenalcellcarcinomapatientstreatedwithneoadjuvantcabozantinibpriortocytoreductivenephrectomywithinthephase2cabopretrial AT alonsogordoateresa addendumacaseseriesofadvancedrenalcellcarcinomapatientstreatedwithneoadjuvantcabozantinibpriortocytoreductivenephrectomywithinthephase2cabopretrial AT rodriguezmorenojuanf addendumacaseseriesofadvancedrenalcellcarcinomapatientstreatedwithneoadjuvantcabozantinibpriortocytoreductivenephrectomywithinthephase2cabopretrial AT carreteroalberto addendumacaseseriesofadvancedrenalcellcarcinomapatientstreatedwithneoadjuvantcabozantinibpriortocytoreductivenephrectomywithinthephase2cabopretrial AT martinsoberonmaricruz addendumacaseseriesofadvancedrenalcellcarcinomapatientstreatedwithneoadjuvantcabozantinibpriortocytoreductivenephrectomywithinthephase2cabopretrial AT delarosakehrmannfederico addendumacaseseriesofadvancedrenalcellcarcinomapatientstreatedwithneoadjuvantcabozantinibpriortocytoreductivenephrectomywithinthephase2cabopretrial AT castellanodaniel addendumacaseseriesofadvancedrenalcellcarcinomapatientstreatedwithneoadjuvantcabozantinibpriortocytoreductivenephrectomywithinthephase2cabopretrial |